Peripheral immune cell markers in children with recurrent respiratory infections in the absence of primary immunodeficiency.
double-negative T cells
memory B cells
recurrent respiratory infections
Journal
Experimental and therapeutic medicine
ISSN: 1792-0981
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
21
05
2019
accepted:
24
06
2019
entrez:
15
8
2019
pubmed:
15
8
2019
medline:
15
8
2019
Statut:
ppublish
Résumé
The immune system of a child has a degree of immaturity that is maintained until 6-7 years of age. Immaturity may be due to age-related functional disorders in the immune response. A healthy child can contract a series of infections which contribute to the maturation of the immune system during the pre-pubertal period. If repeated infections with prolonged or severe complications occur during childhood, the presence of an immunodeficiency should then be considered. Much more frequent than primary immunodeficiency are recurrent infections (frequently involving the upper respiratory tract), which are less severe and occur under the conditions of an immune system with no apparent major defects. A child can present with 4 to 8 episodes of respiratory infections within a year, during the first 5 years of its life. The average duration of infection is 8 days and up to 2 weeks; if the child presents with 3 episodes of acute infections over a period of 6 months, the respiratory infections are then considered recurrent. The aim of this study was to identify the immunological changes or deviations that cause this clinical syndrome in children. For this purpose, 30 children with recurrent respiratory infections and 10 healthy children were included. Immunoglobulin levels were examined and immunophenotyping was performed. We found that the serum immunoglobulin levels were in the normal range in 70% of the children. On the contrary, our data revealed changes in peripheral cell populations, the most important being the decrease in the T-cluster of differentiation (CD)8
Identifiants
pubmed: 31410127
doi: 10.3892/etm.2019.7714
pii: ETM-0-0-7714
pmc: PMC6676098
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1693-1700Références
Br Med Bull. 2002;61:13-28
pubmed: 11997296
Am J Respir Crit Care Med. 2003 Sep 15;168(6):633-9
pubmed: 12773328
J Med Virol. 2003 Oct;71(2):290-7
pubmed: 12938205
Pediatrics. 2006 May;117(5):e878-86
pubmed: 16618789
Mod Pathol. 2007 Jan;20(1):108-19
pubmed: 17143259
J Pediatr. 1992 Feb;120(2 Pt 1):216-22
pubmed: 1735817
Pediatr Allergy Immunol. 2008 Sep;19(6):505-12
pubmed: 18167154
Int Immunopharmacol. 2008 Oct;8(10):1320-9
pubmed: 18687294
Egypt J Immunol. 2008;15(2):153-60
pubmed: 20306698
Mol Med Rep. 2011 Mar-Apr;4(2):267-71
pubmed: 21468562
Allergy Asthma Clin Immunol. 2011 Nov 10;7 Suppl 1:S11
pubmed: 22165913
Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1975-81
pubmed: 22240853
Curr Opin HIV AIDS. 2012 Mar;7(2):164-71
pubmed: 22241163
J Autoimmun. 2013 Feb;40:58-65
pubmed: 22910322
J Family Community Med. 2009 Sep;16(3):77-82
pubmed: 23012196
Paediatr Respir Rev. 2014 Jun;15(2):200-6
pubmed: 24275566
J Virol. 2014 Sep 1;88(17):9655-72
pubmed: 24920804
PLoS One. 2014 Jul 03;9(7):e101469
pubmed: 24992002
Virology (Auckl). 2014;2014(5):1-9
pubmed: 25429207
Immunology. 2015 May;145(1):1-10
pubmed: 25691226
Pediatr Res. 2015 Nov;78(5):483-91
pubmed: 26267154
Pan Afr Med J. 2016 May 12;24:53
pubmed: 27642394
Int J Mol Med. 2018 Mar;41(3):1165-1176
pubmed: 29328393
Pediatrics. 1997 Apr;99(4):639-42
pubmed: 9093321